c="endoscopic retrograde cholangiopancreatography" 13:23 13:25||c="endoscopic retrograde cholangiopancreatography" 13:26 13:28||c="the endoscopic retrograde cholangiopancreatography" 16:0 16:3||c="endoscopic retrograde cholangiopancreatography" 17:8 17:10||c="an endoscopic retrograde cholangiopancreatography" 52:0 52:3||c="endoscopic retrograde cholangiopancreatography" 57:8 57:10||t="coref test"
c="nodularities in the common bile duct" 17:0 17:5||c="nodularity in the common bile duct" 53:6 53:11||c="which" 53:12 53:12||c="region nodularity" 57:0 57:1||c="which" 57:3 57:3||t="coref problem"
c="cholangiocarcinoma" 17:15 17:15||c="cholangiocarcinoma" 53:16 53:16||c="malignancy" 58:5 58:5||t="coref problem"
c="mr. cordano" 13:0 13:1||c="who" 13:16 13:16||c="the patient" 17:17 17:18||c="the patient" 28:0 28:1||c="mr. cordano" 50:0 50:1||c="the patient" 54:2 54:3||c="the patient" 61:0 61:1||c="he" 61:7 61:7||c="the patient" 62:0 62:1||c="he" 63:0 63:0||c="mr. cordano" 66:2 66:3||c="the patient" 68:7 68:8||c="he" 69:0 69:0||c="the patient" 70:5 70:6||c="he" 71:0 71:0||c="the patient" 72:6 72:7||c="he" 72:18 72:18||c="the patient" 73:12 73:13||c="his" 73:21 73:21||c="he" 74:1 74:1||c="he" 76:0 76:0||c="he" 78:0 78:0||c="he" 80:10 80:10||c="the patient" 81:6 81:7||c="his" 83:0 83:0||c="the patient" 84:6 84:7||c="he" 85:3 85:3||c="he" 86:0 86:0||c="he" 86:13 86:13||c="him" 86:21 86:21||c="the patient" 87:5 87:6||t="coref person"
c="hepaticojejunostomy" 54:17 54:17||c="a hepaticojejunostomy" 58:8 58:9||c="the procedure" 61:3 61:4||c="hepaticojejunostomy" 98:4 98:4||t="coref treatment"
c="accumulation of ascitic fluid" 70:15 70:18||c="the ascites" 75:9 75:10||c="which" 75:11 75:11||c="the ascites" 77:5 77:6||t="coref problem"
c="attending" 11:0 11:0||c="terry u cheatom , m.d." 11:2 11:6||t="coref person"
c="primary sclerosing cholangitis" 13:13 13:15||c="psc" 98:0 98:0||c="primary sclerosing cholangitis" 19:3 19:5||t="coref problem"
c="percutaneous transhepatic cholangiogram" 13:30 13:32||c="cholangiogram" 51:4 51:4||t="coref test"
c="the most recent percutaneous transluminal coronary angioplasty" 14:0 14:6||c="placement of percutaneous transhepatic biliary drainage" 21:2 21:7||t="coref treatment"
c="an 8 caucasian catheter" 15:3 15:6||c="placement of 8 caucasian nephrostomy catheter" 21:9 21:14||t="coref treatment"
c="dilation of intrahepatic common bile duct" 47:7 47:12||c="which" 47:13 47:13||t="coref problem"
c="unasyn" 63:3 63:3||c="empiric antibiotic treatment" 63:5 63:7||t="coref treatment"
c="culture" 64:12 64:12||c="which" 64:14 64:14||t="coref test"
c="a prerenal etiology" 67:9 67:11||c="the prerenal kidney failure" 83:18 83:21||t="coref problem"
c="boluses of intravenous fluid" 68:12 68:15||c="normal saline boluses" 78:10 78:12||t="coref treatment"
c="intravenous albumin infusion" 68:17 68:19||c="intravenous albumin" 79:0 79:1||t="coref treatment"
c="100% nonrebreather" 73:17 73:18||c="which" 73:19 73:19||t="coref treatment"
c="paracentesis" 74:10 74:10||c="it" 74:14 74:14||t="coref test"
c="zosyn" 76:3 76:3||c="empiric treatment" 76:5 76:6||t="coref treatment"
c="oxygen requirement" 78:4 78:5||c="oxygen requirement" 81:18 81:19||t="coref problem"
c="prerenal azotemia" 79:5 79:6||c="this condition" 80:7 80:8||t="coref problem"
c="somatostatin" 80:0 80:0||c="the somatostatin" 82:0 82:1||t="coref treatment"
c="midodrine" 80:2 80:2||c="the midodrine" 82:3 82:4||t="coref treatment"
c="lasix" 82:11 82:11||c="furosemide" 90:1 90:1||t="coref treatment"
c="spironolactone" 82:13 82:13||c="spironolactone" 91:1 91:1||t="coref treatment"
c="rocephin" 86:11 86:11||c="rocephin" 89:1 89:1||t="coref treatment"
